Decent Value Stocks. Analyze the stocks with a good fundamental valuation, while still showing decent profitability, health and growth.
We assign a fundamental rating of 7 out of 10 to MRK. MRK was compared to 198 industry peers in the Pharmaceuticals industry. MRK scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MRK is valued quite cheap, while showing a decent growth score. This is a good combination! Finally MRK also has an excellent dividend rating. These ratings would make MRK suitable for value and dividend and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 14.62% | ||
ROE | 36.96% | ||
ROIC | 19.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 34.59% | ||
PM (TTM) | 26.68% | ||
GM | 78.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.74 | ||
Debt/FCF | 2.05 | ||
Altman-Z | 3.81 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.36 | ||
Quick Ratio | 1.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.68 | ||
Fwd PE | 8.33 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 11.57 | ||
EV/EBITDA | 8.71 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.89% |